再生障碍性贫血经抗胸腺细胞球蛋白治疗后转变骨髓增生异常综合征1例
出处
《临床血液学杂志》
CAS
2008年第5期501-502,共2页
Journal of Clinical Hematology
二级参考文献41
-
1Sloand EM, Yong AS, Ramkissoon S, et al. Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform Ⅳ receptor. Proc Natl Acad Sci USA, 2006,103(39) : 14483-14488.
-
2Young NS, Barrett AJ. The treatment of acquired aplastic anemia. Blood, 1995, 85(12):3367-3377.
-
3Saitoh T, Saiki M, Kumagai T, et al. Spontaneous clinical and cytogenetic remission of aplastic anemia in a patient with del (13q). Cancer Genet Cytogenet, 2002,136(2) : 126-128.
-
4Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes.Blood, 1997, 89(6):2079-2088.
-
5Young NS. Acquired aplastic anemia. Ann Intern Med, 2002,136(7):534-546.
-
6Geary CG, Harrison C J, Philpott N J, et al. Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy. Br J Haematol, 1999,104 (2) : 271-274.
-
7Fuhrer M, Burdach S, Ebell W, et al. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatrlc, 1998, 210(4) : 173-179.
-
8Keung YK, Pettenati MJ, Cruz JM, et al. Bone marrow cytogenetic abnormalities of aplastie anemia. Am J Hematol, 2001, 66(3):167-171.
-
9Appelbaum FR, Barrall J, Storb R, et al. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol, 1987,15(11): 1134-1139.
-
10Mikhailova N, Sessarego M, Fugazza G, et al. Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica, 1996,81(5) : 418-422.
共引文献5
-
1杨剑钢,蒋淑莲,张东山,张四方.扶正养营汤对免疫介导再障小鼠骨髓增殖的实验研究[J].中国医师杂志,2005,7(4):498-499. 被引量：1
-
2焦银萍,赵彩源,杜悦欣.再生障碍性贫血转化为骨髓增生异常综合征1例[J].世界最新医学信息文摘,2013,13(25):217-217.
-
3黄邦荣,倪红,张永萍,梁曦.兰州方治疗慢性再生障碍性贫血的临床研究[J].甘肃医药,2017,36(2):114-115.
-
4黄邦荣,张永萍,倪红,李治梅.中药制剂兰州方对免疫介导的再生障碍性贫血模型小鼠骨髓增殖的影响[J].卫生职业教育,2018,36(2):100-102.
-
5杨阳.免疫抑制疗法治疗成人再生障碍性贫血疗效分析[J].临床医药文献电子杂志,2018,5(56):67-67.
-
1秦雪梅,刘传方,彭军,徐从高.应用抗胸腺细胞球蛋白治疗重型再生障碍性贫血并发神经精神病变一例[J].中华血液学杂志,2000,21(10):536-536.
-
2陈友雪,朱霞明.抗胸腺细胞球蛋白治疗再生障碍性贫血30例护理[J].齐齐哈尔医学院学报,2004,25(3):346-347. 被引量：2
-
3严怀秀,牛小青,刘晓伟.抗胸腺细胞球蛋白治疗重型再障一例[J].内蒙古医学杂志,2002,34(1).
-
4和虹,孙晓明,储榆林,邵宗鸿.3例重型再生障碍性贫血经抗胸腺细胞球蛋白治疗后转化为阵发性睡眠性血红蛋白尿症[J].中国医学科学院学报,2001,23(2):201-201. 被引量：2
-
5余继华.抗胸腺细胞球蛋白治疗重型再障的护理[J].深圳医学,1996,9(6):18-18.
-
6张明珙,李杰,屠飞华,王学永,李同义,徐从高,潘祥林,纪春岩,宋强.抗胸腺细胞球蛋白治疗再生障碍性贫血25例临床研究[J].临床血液学杂志,1994,7(4):145-147.
-
7由清秀,曹金霓,侯玉华,李桂珍,白淑华.抗胸腺细胞球蛋白治疗急性再生障碍性贫血[J].天津医药,1995,23(10):625-626.
-
8张明珙,李杰,屠振华,王学永,李同义,徐从高,潘祥林,纪春岩,宋强.抗胸腺细胞球蛋白治疗再生障碍性贫血25例临床研究[J].山东医科大学学报,1996,34(1):63-65.
-
9谢晓恬.抗胸腺细胞球蛋白治疗再生障碍性贫血研究进展[J].世界临床药物,2015,36(5):289-293. 被引量：2
-
10周衔弟.抗胸腺细胞球蛋白治疗重型再生障碍性贫血疗效观察[J].山西临床医药,2001,10(4):256-257. 被引量：6
